TRIALSITEIQ PUBLIC FEASIBILITY SCORECARD · GRADE D-

NCT06689839: Trial of the F2 Filter and Delivery System for Embolic Protection During TAVR

Sponsor: EnCompass Technologies, Inc. · Phase: PHASE2 · Area: CARDIOLOGY_METABOLIC · Target Enrollment: 500 pts

Competing Trials Overlap

8 Active Trials

Excess Burn Exposure

$10,624,000

Rescue Site Savings

+$7,005,200

Unlock Full NCT06689839 Backup Super-Site Packet ($49 One-Time Pass)

Download the complete list of top-decile low-cannibalization clinical sites, verified Principal Investigator (PI) direct emails/phones, and protocol optimization benchmarks.

Download $49 NCT06689839 Rescue Dossier →